# Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer

> **NCT04948437** · — · ACTIVE_NOT_RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 103 (estimated)

## Conditions studied

- Thyroid Cancer
- Papillary Thyroid Cancer
- Follicular Thyroid Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04948437
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-08-19
- **Primary completion:** 2026-04-08
- **Final completion:** 2026-10-31
- **Target enrollment:** 103 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04948437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04948437, "Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04948437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*